🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMASH resolution without worsening fibrosis — need advice Page 3

MASH resolution without worsening fibrosis — need advice

NicoleRaleigh Sun, Dec 28, 2025 at 10:21 AM 11 replies 1,070 viewsPage 3 of 3
SkepticalSean
Member
98
345
Jan 2025
Maine
Dec 31, 2025 at 2:56 PM#11
chris_chi24 said:
Liver ultrasound comparison for liver and MASH: my hepatologist ordered serial ultrasounds to track NAFLD regression.

This answered a question I did not know how to ask. Printing the relevant bit and taking it with me.

37 10DerekSJ_a1c, paige_pharma, emma_london and 34 others
Reply Quote Save Share Report
Dr.LipidDallas
VIP Member
2,678
14,567
Dec 2023
Dallas, TX
Dec 31, 2025 at 10:22 PM#12

From the other side of the consultation, briefly. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

38 11wei_SG, cory_ATX, lori_vegas and 35 others
Reply Quote Save Share Report
NeuroNate
Senior Member
2,890
16,789
Dec 2023
Chicago, IL
Jan 1, 2026 at 5:48 AM#13
LipidDoc_ATL said:
Liver imaging follow-up for liver and MASH: FibroScan at baseline showed CAP score 336 dB/m (moderate steatosis) and stiffness 8.8 kPa (possible…

I read this differently from LipidDoc_ATL, on substance rather than tone. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

39 12sarah_TO, wendy_avl, jason_paloalto and 36 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Jan 1, 2026 at 1:14 PM#14

Adding the numbers, since they settle part of this. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

40 13hans_munich, jason_sac26, chris_chi24 and 37 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jan 1, 2026 at 8:39 PM#15

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here. Report rather than reply if it drifts again.

41 14PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 38 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register